HP Inc vs Sanofi SA — how do they compare? HP Inc trades at $24.86 (market cap $22.15B), while Sanofi SA trades at $44.05 (market cap $104.83B). The key difference: Sanofi SA is far larger — about 4.7× HP Inc's market cap, and Sanofi SA pays the higher dividend (5.5%). Which is the better fit depends on your goals.
| HPQ | SNY | |
|---|---|---|
Market Cap | $22.15B | $104.83B |
Sector | Technology | Health |
52-Week High | $29.35 | $52.34 |
52-Week Low | $18.20 | $41.33 |
Enterprise Value | $29.31B | $121.32B |
Dividend Yield | 4.95% | 5.5% |
Trailing returns across standard periods
Latest headlines on both assets
HP Incorporated is a leading provider of computers, printers, and printer supplies. The company's mains segments are personal systems and printing. Its personal systems segment contains notebooks, desktops, and workstations. Its printing segment contains supplies, consumer hardware, and commercial hardware. In 2015, Hewlett-Packard was separated into HP Incorporated and Hewlett Packard Enterprise and the Palo Alto, California-based HP Incorporated sells on a global scale.
Read more on HPQ →Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →